Sponsor:
Aadi Bioscience, Inc.
Code:
NCT05997017
Conditions
Endometrial Cancer
Endometrioid Tumor
Cancer
Tumor
Recurrent Endometrial Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
nab-sirolimus
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-07. This information was provided to ClinicalTrials.gov by Aadi Bioscience, Inc. on 2024-05-21.